The Cyto-Mine ® platform by Sphere Bio utilizes innovative picodroplet-based technology to capture and screen antibodies directly from entire B cell repertoires, maintaining cell viability and greatly ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...